<DOC>
	<DOCNO>NCT00548002</DOCNO>
	<brief_summary>To study whether fluoroquinolone ( trovafloxacin levofloxacin ) , add standard treatment , could reduce high mortality complication rate Staphylococcus aureus bacteremia .</brief_summary>
	<brief_title>Combination Therapy With Fluoroquinolone Staphylococcus Aureus Bacteremia</brief_title>
	<detailed_description />
	<mesh_term>Sepsis</mesh_term>
	<mesh_term>Bacteremia</mesh_term>
	<mesh_term>Endocarditis</mesh_term>
	<mesh_term>Levofloxacin</mesh_term>
	<mesh_term>Ofloxacin</mesh_term>
	<mesh_term>Fluoroquinolones</mesh_term>
	<mesh_term>Trovafloxacin</mesh_term>
	<mesh_term>Alatrofloxacin</mesh_term>
	<criteria>Adult patient least 1 blood culture positive Staphylococcus aureus include within 1 7 day blood culture sample . age young 18 year imprisonment proven suspected pregnancy breastfeeding , epilepsy another bacteremia previous 28 day polymicrobial bacteremia ( _ &gt; 3 microbe ) history allergy quinolone antibiotic previous tendinitis fluoroquinolone therapy prior fluoroquinolone use 5 day randomization positive culture Staphylococcus aureus central intravenous catheter neutropenia ( &lt; 0.5 x 109/L ) failure supply informed consent patient bacteremia due methicillinresistant S. aureus S. aureus strain resistant fluoroquinolone patient meningitis time randomization</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2007</verification_date>
	<keyword>Staphylococcus aureus</keyword>
	<keyword>bacteremia</keyword>
	<keyword>endocarditis</keyword>
	<keyword>sepsis</keyword>
	<keyword>fluoroquinolone</keyword>
	<keyword>rifampin</keyword>
	<keyword>levofloxacin</keyword>
	<keyword>trovafloxacin</keyword>
</DOC>